Skip to main content

Table 2 Correlation between the clinicopathological features and expression of HOXD3

From: Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling

clinicopathological variables N low(%) high(%) χ2 P value
All cases 164 79 85
Gender
 male 89 41 (46.1) 48 (53.9) 0.345 0.638
 female 75 38 (50.7) 37 (49.3)
Age(years)
  < 56 72 37 (51.4) 35 (48.6) 0.532 0.53
  ≥ 56 92 42 (45.7) 50 (54.3)
Tumor size(cm)
  < 5 96 45 (46.9) 51 (53.1) 0.156 0.752
  ≥ 5 68 34 (50.0) 34 (50.0)
Tumor differentiation
 Good 56 29 (51.8) 27 (48.2) 1.447 0.485
 Moderate 77 38 (49.4) 39 (50.6)
 Poor 31 12 (38.7) 19 (61.3)
T-stage
 T1-T2 31 20 (64.5) 11 (35.5) 4.397 0.111
 T3 127 57 (44.9) 70 (55.1)
 T4 6 2 (33.3) 4 (66.7)
N-stage
 0 98 54 (55.1) 44 (44.9) 4.686 0.038
 1–2 66 25 (37.9) 41 (62.1)
M-stage
 0 152 77 (50.7) 75 (49.3) 5.147 0.033
 1 12 2 (16.7) 10 (83.3)